Campath-1H intravenous
Showing 1 - 25 of >10,000
Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,
Recruiting
- Systemic Sclerosis
- +3 more
- Cyclophosphamide
- +8 more
-
Pittsburgh, Pennsylvania
- +2 more
Dec 17, 2021
Aplastic Anemia Trial run by the NHLBI (Campath-1H, r-ATG, CsA)
Completed
- Aplastic Anemia
- Campath-1H
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 2, 2021
Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell Trial run by the NCI (Alemtuzumab (Campath), EPOCH)
Completed
- Lymphoma, T-Cell
- Lymphoma, Extranodal NK-T-Cell
- Alemtuzumab (Campath)
- EPOCH
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 3, 2022
Sickle Cell Disease Trial in Duarte (drug, procedure, radiation)
Recruiting
- Sickle Cell Disease
- Alemtuzumab
- +3 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Jul 31, 2022
Disorder Related to Renal Transplantation Trial in Madison (Campath-1H)
Terminated
- Disorder Related to Renal Transplantation
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Aug 31, 2020
Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)
Recruiting
- Sickle Cell Disease
- Allogeneic Non-Myeloablative Stem Cell Transplantation
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Feb 16, 2022
Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)
Active, not recruiting
- Leukemia
- Alemtuzumab
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 2, 2022
Immunologic Deficiency Syndromes Trial in Canada, United States (GC5107)
Completed
- Immunologic Deficiency Syndromes
- GC5107
-
Centennial, Colorado
- +19 more
Nov 11, 2022
Gastroenteritis, Bronchiolitis, Sepsis Trial in Montreal (0.9% saline in 5% dextrose (intravenous), 0.45% saline in 5% dextrose
Completed
- Gastroenteritis
- +3 more
- 0.9% saline in 5% dextrose (intravenous)
- 0.45% saline in 5% dextrose (intravenous)
-
Montreal, Quebec, CanadaMontreal Children's Hospital
Apr 4, 2022
Parenteral Nutrition, Home Trial in Canada
Recruiting
- Parenteral Nutrition, Home
-
Calgary, Alberta, Canada
- +9 more
Nov 1, 2022
Colorectal Tumors, Lidocaine Trial in Nantong (Administer 1.5 mg/kg intravenously to the patient before induction of anesthesia,
Recruiting
- Colorectal Tumors
- Lidocaine
- Administer 1.5 mg/kg intravenously to the patient before induction of anesthesia, and continue to infuse 1.5 mg/kg/h during the operation until the end of the operation
-
Nantong, Jiangsu, ChinaAffiliated Hospital of Nantong University
Jul 31, 2022
Inherited Immune Deficiencies Trial run by the NIAID (Campath 1H, Busulfan, Horse Anti-human Thymocyte Globulin (h-ATG))
Completed
- Inherited Immune Deficiencies
- Campath 1H
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 20, 2021
Spinal Muscular Atrophy Trial in Worldwide (OAV101)
Active, not recruiting
- Spinal Muscular Atrophy
- OAV101
-
Boston, Massachusetts
- +12 more
Jan 17, 2023
Hodgkin Lymphoma, DLBCL Trial run by the NCI (campath, Rituximab, EPOCH)
Completed
- Hodgkin Lymphoma
- Diffuse Large B-Cell Lymphoma
- Campath
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 11, 2022
Drug Kinetics, Drug Effects on Physiology Trial in Mount-Royal (sargramostim)
Completed
- Drug Kinetics
- Drug Effects on Physiology
- sargramostim
-
Mount-Royal, Quebec, CanadaAltaSciences
Sep 30, 2022
Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA
Recruiting
- Sickle Cell Anemia
- +2 more
- CD3/CD19 depleted leukocytes
- +6 more
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
May 4, 2022
Intravenous Lidocaine and Immunity Trial in Montréal (intravenous lidocaine (IVL), Placebo)
Recruiting
- Intravenous Lidocaine and Immunity
- intravenous lidocaine (IVL)
- Placebo
-
Montréal, Quebec, CanadaHôpital Maisonneuve-Rosemont, CIUSSS de l'Est de l'Ile de Montré
Oct 1, 2021
Lesion With Known or Suspected F-choline Uptake Trial in Montréal (F-choline intravenous injection)
Recruiting
- Lesion With Known or Suspected F-choline Uptake
- F-choline intravenous injection
-
Montréal, Quebec, CanadaCentre Hospitalier de l'université de Montréal
Dec 6, 2022
Lymphoma, Leukemia Trial in Houston (drug, other, radiation, procedure)
Idiopathic Pulmonary Fibrosis, Emphysema or COPD Trial in Pittsburgh (CD3/CD19 negative hematopoietic stem cells, Rituximab,
Recruiting
- Idiopathic Pulmonary Fibrosis
- Emphysema or COPD
- CD3/CD19 negative hematopoietic stem cells
- +6 more
-
Pittsburgh, Pennsylvania
- +1 more
Feb 9, 2022
Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)
Recruiting
- Crohn's Disease
- autologous CD34-selected peripheral blood stem cells transplant
- +8 more
-
Pittsburgh, Pennsylvania
- +1 more
Feb 9, 2022
Dislodged Catheter Trial in Ottawa (Cyanoacrylate glue, Transparent polyurethane dressing)
Recruiting
- Dislodged Catheter
- Cyanoacrylate glue
- Transparent polyurethane dressing
-
Ottawa, Ontario, CanadaChildren's Hospital Of Eastern Ontario
Jul 27, 2021
N-13 Ammonia Safety Trial in Montréal (N-13 ammonia intravenous injection)
Recruiting
- N-13 Ammonia Safety
- N-13 ammonia intravenous injection
-
Montréal, Quebec, CanadaCentre Hospitalier de l'université de Montréal
Aug 5, 2022
Chordoma, Breast Cancer, Gastric/Gastroesophageal Junction Cancer Trial in United States (TAEK-VAC-HerBy)
Recruiting
- Chordoma
- +2 more
- TAEK-VAC-HerBy
-
Scottsdale, Arizona
- +8 more
Oct 27, 2022